Drugs Made In America Acquisition Income Statement (2024-2025) | DMAA

1Y3Y5Y7Y10YAll
Download Data
Income Statement Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Operating items
Selling, General & Administrative (Quarter) 0.33M0.13M0.26M2.09M
Operating Expenses (Quarter) 0.33M0.13M0.26M2.09M
Operating Income (Quarter) -0.33M-0.13M-0.26M-2.09M
EBIT (Quarter) -0.33M-0.13M-0.26M-2.09M
Non-operating items
Interest & Investment Income (Quarter) 1.59M2.42M2.45M2.30M
Non Operating Income (Quarter) 2.42M2.45M2.30M
Net income details
EBT (Quarter) 1.25M2.29M2.18M0.21M
Profit After Tax (Quarter) 1.25M2.29M2.18M0.21M
Income from Continuing Operations (Quarter) 1.25M2.29M2.18M0.21M
Consolidated Net Income (Quarter) 1.25M2.29M2.18M0.21M
Income towards Parent Company (Quarter) 1.25M2.29M2.18M0.21M
Net Income towards Common Stockholders (Quarter) 0.77M1.57M1.50M-1.82M
Additional items
EPS (Basic) (Quarter) 0.050.070.07-0.09
EPS (Weighted Average and Diluted) (Quarter) 0.050.070.07-0.09
Shares Outstanding (Weighted Average) (Quarter) 8.57M15.18M19.11M20.34M21.01M
Shares Outstanding (Diluted Average) (Quarter) 8.57M10.33M19.11M20.34M21.01M
EBITDA (Quarter) -0.33M-0.13M-0.26M-2.09M
Shares Outstanding (Quarter) 9.86M10.52M10.52M10.52M10.72M